Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs

Recombinant vectors based on human adenovirus serotype 5 (HAdV-5) have been extensively studied in preclinical models and clinical trials over the past two decades. However, the thorough understanding of the HAdV-5 interaction with human subjects has uncovered major concerns about its product applic...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso-Padilla, Julio, Papp, Tibor, Kaján, Győző L, Benkő, Mária, Havenga, Menzo, Lemckert, Angelique, Harrach, Balázs, Baker, Andrew H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754553/
https://www.ncbi.nlm.nih.gov/pubmed/26478249
http://dx.doi.org/10.1038/mt.2015.194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754553/
https://www.ncbi.nlm.nih.gov/pubmed/26478249
http://dx.doi.org/10.1038/mt.2015.194

Ejemplares similares